API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209883
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/two-painkillers-tapentadol-and-pregabalin-may-go-off-otc-over-misuse/articleshow/105482448.cms
https://www.ema.europa.eu/en/documents/overview/pregabalin-sandoz-gmbh-epar-summary-public_en.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214496
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215675
https://www.expresspharma.in/us-fda-approves-venlafaxine-extended-release-tablets-and-pregabalin-extended-release-tablets-by-zydus/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207883
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215577
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216197
https://health.economictimes.indiatimes.com/news/pharma/lupin-receives-usfda-approval-to-market-generic-pregabalin-capsules/91376335
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091040
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215249
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212988
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212604
https://www.livemint.com/companies/news/sun-pharma-lupin-recall-products-in-us-market-11642310935658.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211967
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-6-2021-1633509984.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213313
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211687
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213226
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211948
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211889
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211593
https://www.pharmacompass.com/pdf/news/health-canada-issues-recalls-of-pharmascience-s-pms-pregabalin-50mg-1608716099.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211948
https://pfe-pfizercom-d8-prod.s3.amazonaws.com/2020-08/Final-Pfizer-Statement-on-Lyrica-Patent-Infringment-in-Japan.pdf?VPN0TpvJqxlt4CHCfrrs85unLOGQHdcY
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091025
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213423
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212865
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211593
https://uk.reuters.com/article/us-pfizer-results/pfizer-posts-9-fall-in-fourth-quarter-revenue-idUKKBN1ZR1AX
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212280
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210585
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206912
https://www.fiercepharma.com/pharma/icer-lambasts-abbvie-s-humira-genentech-s-rituxan-and-more-for-unsupported-price-hikes
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210891
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091228
https://endpts.com/once-touted-as-lyrica-rival-for-diabetic-nerve-pain-korean-biotechs-plasmid-product-implodes-in-phiii/
https://www.fiercepharma.com/pharma/pfizer-could-merge-off-patent-drug-business-mylan-and-analysts-already-like-sound-it
http://www.pharmafile.com/news/524948/fda-approves-nine-generic-versions-pfizers-lyrica
https://www.in-pharmatechnologist.com/Article/2019/07/23/First-generics-of-Lyrica-receive-FDA-approval
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207623
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208677
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209357
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209664
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209743
https://www.fiercepharma.com/pharma/lyrica-generics-roll-pfizer-finally-hits-patent-cliff-for-nerve-pain-and-fibromyalgia
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211384
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203459